⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockNetherlandsNasdaqGS

ARGX

argenx SE

Healthcare · Biotechnology

873.705USD

-2.0550 (-0.23%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on ARGX.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 873.71
P/E32.0
Dvd Ind Yld0.0%
P/B6.53
P/S10.5
Curr EV/T12M EBITDA1,256.9
Mkt Cap (USD)54.9B
Curr EV (USD)1,360.9B
2)

Per Share Data

EPS T12M21.35
DPS—
Bk Val Per Sh5.38
Rev/Sh78.78
Cash/Sh3.32
Curr Shares Out62.9M
FCF/Sh8.64
3)

Cash Flow Analysis

P/CF80.2
Curr P/FCF95.8
CF/NI0.4
Dvd P/O0.0%
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales13.1%
Eff Interest Rate8.1%
4)

Growth Potential

Dil EPS 1Y Gr53.1%
Cap 1Y Gr33.2%
BPS 1Y Gr31.5%
R&D To Sales31.7%
Retention Rate100.0%
Rev 1Y Gr89.6%
FCF 1Y Gr479.7%
Assets 1Y Gr40.0%
5)

Profitability

EBITDA1.1B
EBIT1.6B
Operating Margin30.6%
Pretax Margin33.4%
Net Margin32.8%
ROA23.5%
ROE27.4%
ROC18.5%
Asset Turnover0.72
6)

Structure

Current Ratio5.12
Quick Ratio—
Debt/Assets0.5%
Debt/Com Eq0.6%
Net Debt/EBITDA-3.27
Tot Debt/Capital0.6%
Gross Margin90.0%
EBIT/Int Exp418.1

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.